Ocular Therapeutix, Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC OCUL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

307,747

Value ($000)

3,736

Weight

0.0%

2020 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,736	0.0%	307,747	12/31/2025
2025 Q3	11/14/2025	2,353	0.0%	201,259	9/30/2025
2025 Q2	8/14/2025	2,935	0.0%	316,276	6/30/2025
2025 Q1	5/19/2025	1,561	0.0%	212,952	3/31/2025
2024 Q4	2/14/2025	1,867	0.0%	218,588	12/31/2024
2024 Q3	11/14/2024	1,285	0.0%	147,684	9/30/2024
2024 Q2	8/14/2024	1,273	0.0%	186,060	6/30/2024
2022 Q1	5/16/2022	501	0.0%	101,123	3/31/2022
2021 Q4	2/14/2022	551	0.0%	79,058	12/31/2021
2021 Q3	11/15/2021	686	0.0%	68,621	9/30/2021
2021 Q2	8/16/2021	1,067	0.0%	75,220	6/30/2021
2021 Q1	5/14/2021	1,025	0.0%	62,448	3/31/2021
2020 Q4	3/1/2021	1,038	0.0%	50,137	12/31/2020